Paper190995
A nonproducer T lymphoblastoid cell line from Marek's disease transplantable tumor (JMV).
Nazerian K and 5 others. Avian Dis, 1977. Cited by 119 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. A nonproducer T lymphoblastoid cell line from Marek's disease transplantable tumor (JMV). Papers, record 190995. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/190995
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- A nonproducer T lymphoblastoid cell line from Marek's disease transplantable tumor (JMV).
- PubMed
Connected records1
Records in the library's other databases whose lists name this one, each read from that database's own release: up to 20 of each kind, the most connected first.
Cell lines1
Source Cell lines
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cell Line | Major topic |
| Chickens | Major topic |
| Marek Disease | Major topic |
| T-Lymphocytes | Major topic |
| Animals | |
| Antigens, Neoplasm | |
| Antigens, Viral | |
| DNA, Viral | |
| Herpesvirus 2, Gallid | |
| Histocompatibility Antigens | |
| Neoplasm Transplantation | |
| Nucleic Acid Hybridization | |
| Spleen | |
| Transplantation, Homologous |
Source PubMed
Cited by18
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 119 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 36146821 | The Importance of the Bursa of Fabricius, B Cells and T Cells for the Pathogenesis of Marek's Disease: A Review. | Viruses | 2022 | https://conductscience.org/library/papers/36146821 | PubMed |
| 26612074 | Marek's disease virus undergoes complete morphogenesis after reactivation in a T-lymphoblastoid cell line transformed by recombinant fluorescent marker virus. | J Gen Virol | 2016 | https://conductscience.org/library/papers/26612074 | PubMed |
| 22090140 | Epigenetic regulation of the latency-associated region of Marek's disease virus in tumor-derived T-cell lines and primary lymphoma. | J Virol | 2012 | https://conductscience.org/library/papers/22090140 | PubMed |
| 21573129 | Clonal structure of rapid-onset MDV-driven CD4+ lymphomas and responding CD8+ T cells. | PLoS Pathog | 2011 | https://conductscience.org/library/papers/21573129 | PubMed |
| 21302075 | Histocompatibility typing by cellular radioimmunoassay. | Immunogenetics | 1978 | https://conductscience.org/library/papers/21302075 | PubMed |
| 17016434 | The activation of TC10, a Rho small GTPase, contributes to v-Rel-mediated transformation. | Oncogene | 2007 | https://conductscience.org/library/papers/17016434 | PubMed |
| 16352553 | Mechanism of telomerase activation by v-Rel and its contribution to transformation. | J Virol | 2006 | https://conductscience.org/library/papers/16352553 | PubMed |
| 12072527 | Identification of the neoplastically transformed cells in Marek's disease herpesvirus-induced lymphomas: recognition by the monoclonal antibody AV37. | J Virol | 2002 | https://conductscience.org/library/papers/12072527 | PubMed |
| 11997525 | A novel interferon regulatory factor (IRF), IRF-10, has a unique role in immune defense and is induced by the v-Rel oncoprotein. | Mol Cell Biol | 2002 | https://conductscience.org/library/papers/11997525 | PubMed |
| 11533227 | Interferon regulatory factor 4 contributes to transformation of v-Rel-expressing fibroblasts. | Mol Cell Biol | 2001 | https://conductscience.org/library/papers/11533227 | PubMed |
| 9420237 | Transforming potential of the herpesvirus oncoprotein MEQ: morphological transformation, serum-independent growth, and inhibition of apoptosis. | J Virol | 1998 | https://conductscience.org/library/papers/9420237 | PubMed |
| 7710361 | Identification and characterization of a cDNA clone derived from the Marek's disease tumour cell line RPL1 encoding a homologue of alpha-transinducing factor (VP16) of HSV-1. | Arch Virol | 1995 | https://conductscience.org/library/papers/7710361 | PubMed |
| 6874076 | Development and characterization of monoclonal antibodies to Marek's disease tumor-associated surface antigen. | Infect Immun | 1983 | https://conductscience.org/library/papers/6874076 | PubMed |
| 6287971 | Circular forms of viral DNA in Marek's disease virus-transformed lymphoblastoid cells. | Arch Virol | 1982 | https://conductscience.org/library/papers/6287971 | PubMed |
| 6273319 | Spontaneous and induced herpesvirus genome expression in Marek's disease tumor cell lines. | Infect Immun | 1981 | https://conductscience.org/library/papers/6273319 | PubMed |
| 6251256 | Replication of the resident Marek's Disease virus genome in synchronized nonproducer MKT-1 cells. | J Virol | 1980 | https://conductscience.org/library/papers/6251256 | PubMed |
| 1315048 | Marek disease virus encodes a basic-leucine zipper gene resembling the fos/jun oncogenes that is highly expressed in lymphoblastoid tumors. | Proc Natl Acad Sci U S A | 1992 | https://conductscience.org/library/papers/1315048 | PubMed |
| 227789 | In vitro replication of infectious bursal disease virus in established lymphoid cell lines and chicken B lymphocytes. | Infect Immun | 1979 | https://conductscience.org/library/papers/227789 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/190995
GET https://conductscience.org/api/papers/v1/190995/authors